Antidote Technologies raised €9.4M in a funding round in Aug 2017. The company is based in London, UK. Investors in the round: Merck Global Health Innovation Fund. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
